Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
1.59
Dollar change
-0.19
Percentage change
-10.67
%
Index- P/E- EPS (ttm)-1.00 Insider Own6.03% Shs Outstand30.33M Perf Week9.66%
Market Cap49.35M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float29.17M Perf Month70.97%
Income-23.28M PEG- EPS next Q-0.16 Inst Own22.32% Short Float3.61% Perf Quarter34.75%
Sales8.32M P/S5.93 EPS this Y32.22% Inst Trans-3.45% Short Ratio6.27 Perf Half Y169.45%
Book/sh0.27 P/B5.95 EPS next Y-16.80% ROA-49.23% Short Interest1.05M Perf Year-71.30%
Cash/sh0.69 P/C2.30 EPS next 5Y15.00% ROE-196.94% 52W Range0.47 - 5.62 Perf YTD169.49%
Dividend Est.- P/FCF- EPS past 5Y5.33% ROI-216.24% 52W High-71.69% Beta1.06
Dividend TTM- Quick Ratio0.96 Sales past 5Y-3.23% Gross Margin82.49% 52W Low238.08% ATR (14)0.17
Dividend Ex-Date- Current Ratio1.05 EPS Y/Y TTM45.21% Oper. Margin-379.51% RSI (14)57.56 Volatility11.53% 13.62%
Employees58 Debt/Eq2.21 Sales Y/Y TTM-57.16% Profit Margin-279.77% Recom1.67 Target Price6.75
Option/ShortYes / Yes LT Debt/Eq0.30 EPS Q/Q50.54% Payout- Rel Volume1.15 Prev Close1.78
Sales Surprise-32.95% EPS Surprise-21.95% Sales Q/Q-11.05% EarningsMay 13 AMC Avg Volume167.94K Price1.59
SMA209.13% SMA5038.53% SMA20019.09% Trades Volume190,985 Change-10.67%
Date Action Analyst Rating Change Price Target Change
Oct-30-20Initiated Chardan Capital Markets Buy $7
Oct-12-20Initiated ROTH Capital Buy
Jul-31-20Initiated Oppenheimer Outperform $7
Jan-31-20Initiated B. Riley FBR Buy $5
Nov-18-19Resumed Cantor Fitzgerald Overweight
Sep-06-19Initiated Cantor Fitzgerald Overweight $5
Mar-06-18Upgrade H.C. Wainwright Neutral → Buy $3.50
Oct-20-17Reiterated Laidlaw Buy $3 → $2
Oct-20-17Downgrade Stifel Buy → Hold $3 → $0.90
Oct-20-17Downgrade H.C. Wainwright Buy → Neutral
Jun-19-24 09:40AM
May-21-24 11:17AM
08:00AM
May-14-24 01:21PM
11:44AM
08:20AM Loading…
08:20AM
03:03AM
May-13-24 08:54PM
05:20PM
04:17PM
04:05PM
May-07-24 04:30PM
Apr-30-24 07:00AM
Apr-01-24 02:11PM
Mar-27-24 08:53PM
05:10PM Loading…
05:10PM
04:19PM
04:01PM
Mar-20-24 04:30PM
Mar-04-24 07:00AM
Feb-07-24 06:48PM
Nov-14-23 08:05AM
Nov-13-23 04:40PM
04:05PM
Nov-09-23 04:30PM
Nov-08-23 08:40AM
07:59AM
Nov-07-23 04:01PM
Oct-19-23 10:44AM
Oct-02-23 03:07PM
07:00AM Loading…
Sep-07-23 07:00AM
Aug-31-23 04:30PM
Aug-14-23 07:55AM
Aug-10-23 07:08AM
Aug-09-23 05:50PM
04:43PM
04:05PM
Aug-03-23 04:30PM
Jul-28-23 04:19PM
Jul-20-23 08:00AM
Jun-07-23 06:00AM
May-11-23 09:55AM
May-08-23 05:25PM
04:23PM
04:05PM
May-01-23 07:03PM
Apr-27-23 05:11PM
Apr-25-23 06:45PM
Apr-10-23 06:00AM
Mar-24-23 06:30AM
Mar-21-23 04:30PM
Mar-11-23 07:33AM
Mar-09-23 08:30AM
Mar-08-23 05:53AM
Mar-07-23 05:35PM
04:05PM
Feb-28-23 06:07PM
Feb-17-23 06:30AM
Feb-03-23 05:17PM
Jan-11-23 07:59AM
Nov-28-22 06:46PM
Nov-02-22 06:05PM
04:05PM
Oct-26-22 08:30AM
Oct-06-22 08:30AM
Sep-26-22 08:30AM
Sep-06-22 08:00AM
Aug-08-22 06:09AM
Aug-04-22 07:35PM
04:05PM
Jul-27-22 04:15PM
Jul-24-22 08:41AM
Jul-15-22 06:15AM
Jul-05-22 08:30AM
Jun-18-22 08:05AM
May-31-22 06:21AM
May-18-22 01:53PM
May-08-22 08:19AM
May-04-22 06:25PM
04:05PM
Apr-27-22 04:15PM
Mar-24-22 09:30AM
Mar-23-22 04:15PM
01:29PM
Mar-09-22 04:30PM
Mar-07-22 05:25PM
04:05PM
Mar-01-22 08:30AM
Feb-28-22 04:30PM
09:15AM
Jan-13-22 10:00AM
Jan-06-22 04:05PM
Dec-22-21 07:30AM
05:45AM
Dec-14-21 09:00AM
Nov-29-21 09:00AM
Nov-12-21 09:00AM
Nov-10-21 09:00AM
Nov-08-21 09:00AM
Nov-07-21 07:45AM
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.